FNCH insider filings

Finch Therapeutics Group, Inc. — 42 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2024-06-10. Screen FNCH transaction legs live →

Insider transaction summary — last 90 days

No insider filings (Forms 3/4/5) for FNCH between 2026-08-23 and 2026-11-21. The table below lists the most recent filings on record.

Recent insider filings — Finch Therapeutics Group, Inc.

FiledFormInsiderReported transactionsSource
2024-06-104SMISEK JEFFERY A — DirectorGift (G): 384 @ $0 · Gift (G): 383 @ $0EDGAR
2024-05-244SMISEK JEFFERY A — DirectorGift (G): 3,750 @ $0EDGAR
2024-03-294SMISEK JEFFERY A — DirectorSale (S): 6,642 @ $2.57 · Sale (S): 1,600 @ $2.61EDGAR
2023-11-274SMISEK JEFFERY A — DirectorSale (S): 1,470 @ $3.64EDGAR
2023-06-234/ABlischak Matthew P. — Chief Executive OfficerGrant/award (A): 962,899 (derivative) @ $0EDGAR
2023-06-094Blischak Matthew P. — Chief Executive OfficerGrant/award (A): 962,899 (derivative) @ $0EDGAR
2023-06-094Lange Christian H. — DirectorGrant/award (A): 10,000 (derivative) @ $0EDGAR
2023-06-094Haft Nicholas — DirectorGrant/award (A): 10,000 (derivative) @ $0EDGAR
2023-06-094Graf Susan E — DirectorPurchase (P): 5,010 @ $0.27 · Grant/award (A): 10,000 (derivative) @ $0EDGAR
2023-06-094Shumway Chris — Director, 10% ownerGrant/award (A): 10,000 (derivative) @ $0EDGAR
2023-06-094FERRANTE DOMENIC J — DirectorGrant/award (A): 10,000 (derivative) @ $0EDGAR
2023-06-094SMISEK JEFFERY A — DirectorGrant/award (A): 10,000 (derivative) @ $0EDGAR
2023-02-234Blaustein Marc — Chief Operating OfficerSale (S): 4,619 @ $0.38EDGAR
2022-10-254Blaustein Marc — Chief Operating OfficerSale (S): 3,636 @ $1.39EDGAR
2022-10-254Vittiglio Joseph — Chief Business & Legal OfficerSale (S): 3,636 @ $1.39EDGAR
2022-06-154Lange Christian H. — DirectorGrant/award (A): 44,843 (derivative) @ $0EDGAR
2022-06-154Blaustein Marc — Chief Operating OfficerGrant/award (A): 35,000 @ $0EDGAR
2022-06-154Viney Joanne L. — DirectorGrant/award (A): 44,843 (derivative) @ $0EDGAR
2022-06-154Haft Nicholas — DirectorGrant/award (A): 44,843 (derivative) @ $0EDGAR
2022-06-154Hamood Samuel A — DirectorGrant/award (A): 44,843 (derivative) @ $0EDGAR
2022-06-154Graf Susan E — DirectorGrant/award (A): 44,843 (derivative) @ $0EDGAR
2022-06-154Vittiglio Joseph — Chief Business & Legal OfficerGrant/award (A): 35,000 @ $0EDGAR
2022-06-154Shumway Chris — Director, 10% ownerGrant/award (A): 44,843 (derivative) @ $0EDGAR
2022-06-154FERRANTE DOMENIC J — DirectorGrant/award (A): 44,843 (derivative) @ $0EDGAR
2022-06-154SMISEK JEFFERY A — DirectorGrant/award (A): 44,843 (derivative) @ $0EDGAR
2022-02-284Blaustein Marc — Chief Operating OfficerGrant/award (A): 38,000 (derivative) @ $0EDGAR
2022-02-284Vittiglio Joseph — Chief Business & Legal OfficerGrant/award (A): 75,000 (derivative) @ $0EDGAR
2022-02-284PERRY GREGORY D — Chief Financial OfficerGrant/award (A): 80,000 (derivative) @ $0EDGAR
2021-12-224Haft Nicholas — DirectorPurchase (P): 63,850 @ $10.18EDGAR
2021-12-214Vittiglio Joseph — Chief Business & Legal OfficerGrant/award (A): 125,000 (derivative) @ $0EDGAR
2021-10-054Hamood Samuel A — DirectorGrant/award (A): 25,543 (derivative) @ $0EDGAR
2021-09-104Blaustein Marc — Chief Operating OfficerGrant/award (A): 150,000 (derivative) @ $0EDGAR
2021-05-144Viney Joanne L. — DirectorGrant/award (A): 23,419 (derivative) @ $0EDGAR
2021-04-274Graf Susan E — DirectorGrant/award (A): 23,419 (derivative) @ $0EDGAR
2021-03-254Haft Nicholas — DirectorConversion (C): 172,942 · Conversion (C): 143,831 · Conversion (C): 1,064,466 · Conversion (C): 366,093 · Conversion (C): 212,893 · Conversion (C): 1,150,481 · +7 moreEDGAR
2021-03-254Crestovo Investor LLC — Director, 10% owner
Shumway Chris — Director, 10% owner
Conversion (C): 11,906,147 · Purchase (P): 735,294 @ $17 · Conversion (C): 8,672,117 (derivative) · Conversion (C): 1,064,466 (derivative) · Conversion (C): 1,172,480 (derivative) · Conversion (C): 997,084 (derivative)EDGAR
2021-03-254FERRANTE DOMENIC J — DirectorConversion (C): 141,928 · Conversion (C): 300,948 · Conversion (C): 90,378 · Purchase (P): 102,941 @ $17 · Conversion (C): 141,928 (derivative) @ $0 · Conversion (C): 300,948 (derivative) @ $0 · +1 moreEDGAR
2021-03-254SMISEK JEFFERY A — DirectorConversion (C): 894,955 · Conversion (C): 141,928 · Conversion (C): 297,178 · Conversion (C): 272,245 · Purchase (P): 88,235 @ $17 · Conversion (C): 894,955 (derivative) @ $0 · +3 moreEDGAR
2021-03-184Smith Mark Burnham — Chief Executive Officer, DirectorGrant/award (A): 595,402 (derivative) @ $0EDGAR
2021-03-184Kassam Zain — Chief Medical OfficerGrant/award (A): 69,232 (derivative) @ $0EDGAR
2021-03-184Vittiglio Joseph — General Counsel and SecretaryGrant/award (A): 34,616 (derivative) @ $0 · Grant/award (A): 60,578 (derivative) @ $0EDGAR
2021-03-184PERRY GREGORY D — Chief Financial OfficerGrant/award (A): 55,386 (derivative) @ $0EDGAR

Recent 8-K events — Finch Therapeutics Group, Inc.

Items classified from EDGAR index headers. Browse recent 8-K filings market-wide, by item code →

FiledFormItems reportedSource
2024-10-218-K3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
2024-08-128-K8.01 — Other EventsEDGAR
2024-05-248-K3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of ListingEDGAR
2024-05-178-K3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of ListingEDGAR
2024-04-038-K3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of ListingEDGAR
2024-02-238-K3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
8.01 — Other Events
EDGAR
2023-11-178-K3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of ListingEDGAR
2023-07-078-K1.02 — Termination of a Material Definitive AgreementEDGAR
2023-06-288-K8.01 — Other EventsEDGAR
2023-06-238-K5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain OfficersEDGAR
Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?ticker=FNCH returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. Get a free API key → · API docs